Gossamer Bio(GOSS)
$10.97-0.27 (-2.40%)
GOSS
Gossamer Bio financials statements
$10.97
At close:-0.27 (-2.40%)
Want to see GOSS full AI Analyst Report?
Gossamer Bio (GOSS) Ratios
1,467 Followers
Gossamer Bio Ratios
GOSS's free cash flow for Q3 2026 was $-29.58M. For the 2026 fiscal year, GOSS's free cash flow was increased by $0.00 and operating cash flow was $-29.58M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.64 | 6.88 | 5.94 | 5.32 | 8.32 |
| Quick Ratio | 2.64 | 6.88 | 5.94 | 5.32 | 8.32 |
| Cash Ratio | 0.59 | 1.02 | 0.62 | 2.27 | 4.60 |
| Solvency Ratio | -0.57 | -0.18 | -0.70 | -0.86 | -1.03 |
| Operating Cash Flow Ratio | -2.70 | -0.08 | -3.08 | -3.80 | -4.74 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -13.71 | -16.11 | 0.00 |
| Net Current Asset Value | $ -127.36M | $ 24.09M | $ 57.37M | $ 1.51M | $ 109.59M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.18 | 0.64 | 0.68 | 0.83 | 0.54 |
| Debt-to-Equity Ratio | -1.65 | 6.88 | 3.38 | 18.69 | 1.53 |
| Debt-to-Capital Ratio | 2.53 | 0.87 | 0.77 | 0.95 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 2.62 | 0.87 | 0.76 | 0.95 | 0.60 |
| Financial Leverage Ratio | -1.40 | 10.69 | 4.97 | 22.56 | 2.83 |
| Debt Service Coverage Ratio | -14.41 | -3.55 | -6.44 | -8.28 | -10.77 |
| Interest Coverage Ratio | -14.86 | -5.20 | -13.60 | -15.75 | -11.12 |
| Debt to Market Cap | 0.28 | 0.97 | 1.02 | 1.19 | 0.21 |
| Interest Debt Per Share | 74.88 | 0.95 | 1.00 | 2.83 | 2.73 |
| Net Debt to EBITDA | -1.04 | -3.92 | -1.11 | -0.54 | -0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 97.93% | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -329.00% | -38.46% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -326.93% | -34.84% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -336.81% | -52.24% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -351.67% | -48.50% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -351.49% | -49.28% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -351.49% | -49.28% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.95% | 101.61% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 104.41% | 92.85% | 97.85% | 104.93% | 108.27% |
| Return on Assets (ROA) | -98.91% | -17.93% | -57.65% | -84.19% | -68.09% |
| Return on Equity (ROE) | 138.78% | -191.67% | -286.47% | -1899.30% | -192.65% |
| Return on Capital Employed (ROCE) | -150.03% | -22.17% | -70.59% | -97.93% | -71.14% |
| Return on Invested Capital (ROIC) | -148.67% | -22.09% | -66.76% | -91.92% | -70.47% |
| Return on Tangible Assets | -98.91% | -17.93% | -57.65% | -84.19% | -68.09% |
| Earnings Yield | -24.05% | -27.62% | -87.36% | -124.98% | -27.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.87 | 21.49 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 11.55 | 22.40 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.28 | 0.36 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.26 | 0.44 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -2076.36 | 16.99 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 94.33 | 16.99 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2170.69 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 94.33 | 16.99 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -59.96 | -0.02 | -0.71 | -2.21 | -2.52 |
| Free Cash Flow Per Share | -59.98 | -0.02 | -0.71 | -2.22 | -2.55 |
| Dividend Paid and CapEx Coverage Ratio | -2167.92 | 0.00 | 0.00 | -393.75 | -116.53 |
| Capital Expenditure Coverage Ratio | -2167.92 | 0.00 | 0.00 | -393.75 | -116.53 |
| Operating Cash Flow Coverage Ratio | -0.84 | -0.02 | -0.75 | -0.83 | -1.02 |
| Operating Cash Flow to Sales Ratio | -3.53 | -0.03 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -24.19% | -1.69% | -77.32% | -102.17% | -22.51% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.16 | -3.62 | -1.14 | -0.80 | -3.62 |
| Price-to-Sales (P/S) Ratio | 14.62 | 1.78 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -5.77 | 6.94 | 3.28 | 15.20 | 6.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.13 | -59.01 | -1.29 | -0.98 | -4.44 |
| Price-to-Operating Cash Flow Ratio | -4.14 | -59.01 | -1.29 | -0.98 | -4.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.05 | 0.02 | 0.05 | 0.39 |
| Enterprise Value Multiple | -5.51 | -9.04 | -2.39 | -1.41 | -4.05 |
| Enterprise Value | 873.58M | 361.45M | 386.19M | 297.29M | 848.31M |
| EV to EBITDA | -5.51 | -9.04 | -2.39 | -1.41 | -4.05 |
| EV to Sales | 18.02 | 3.15 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.10 | -104.23 | -2.43 | -1.59 | -4.45 |
| EV to Operating Cash Flow | -5.10 | -104.23 | -2.43 | -1.59 | -4.49 |
| Tangible Book Value Per Share | -42.98 | 0.13 | 0.28 | 0.14 | 1.62 |
| Shareholders’ Equity Per Share | -42.98 | 0.13 | 0.28 | 0.14 | 1.62 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 16.97 | 0.51 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -59.64 | -0.25 | -0.80 | -2.71 | -3.13 |
| Tax Burden | 1.00 | 1.02 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.07 | 1.26 | 1.08 | 1.06 | 1.09 |
| Research & Development to Revenue | 3.59 | 1.21 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.78 | 0.32 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.22 | 0.18 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.01 | 0.06 | 0.89 | 0.82 | 0.81 |
Currency in USD

